Parathyroid hormone-related protein as a potential tumor marker: A case report of ovarian clear cell carcinoma

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 1, 2006, Pages 94-98

  Suwaki, Naoko ^a   Masuyama, Hisashi ^a,b   Mizutani, Yasushi ^a   Kodama, Junichi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE   (Japan)

Author keywords

Clear cell carcinoma; Hypercalcemia; Ovarian cancer; Parathyroid hormone related protein

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; LOOP DIURETIC AGENT; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; CALCIUM BLOOD LEVEL; CANCER RECURRENCE; CASE REPORT; CLEAR CELL CARCINOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; OVARY CARCINOMA; OVARY TUMOR; PARANEOPLASTIC SYNDROME; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, CLEAR CELL; FEMALE; HUMANS; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; RETROPERITONEAL NEOPLASMS; SPLENIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645217341     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00358.x     Document Type: Article

References (22)

1. Roberts MM Stewart AF. Humoral hypercalcemia of malignancy. In Favus MJ (ed.). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th edn. Philadelphia Lippincott Williams & Wilkins 1999 203 207.
2. Young RH Olive E Scully RE. Small cell carcinoma of the ovary hypercalcemic type. Am J Surg Pathol 1994 18 1102 1116.
3. Clement PB Young RH Scully RE. Clinical syndromes associated with tumors of the female genital tract. Semin Diagn Pathol 1991 8 204 233.
4. Walsh CA Birch MA Fraser WD et al. Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: Effects of glucocorticoids. J Bone Miner Res 1995 10 17 25.
5. Tsunematsu R Saito T Iguchi H Fukuda T Tsukamoto N. Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: Case report. Gynecol Oncol 2000 76 218 222.
6. Kitazawa R Kitazawa S Matsui T Maeda S. In situ detection of parathyroid hormone-related protein in ovarian clear cell carcinoma. Hum Pathol 1997 28 379 382.
7. Koshiyama M Fujii H Konishi M et al. Recurrent clear cell carcinoma of the ovary changing into producing parathyroid hormone-related protein (PTHrP) with hypercalcemia. Eur J Obstet Gynecol 1999 82 227 229.
8. Fujino T Watanabe T Yamaguchi K et al. The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer 1992 70 2845 2850.
9. Hoekman K Tjandra YI Papapoulos SE. The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein. Cancer 1991 68 642 647.
10. Savage MW Fraser WD Bodmer CW Ginty AF Robinson J Williams G. Hypercalcemia due to parathyroid hormone-related protein: Long-term circulating levels may not reflect tumor activity. Clin Endocrinol 1993 39 695 698.
11. Bucht E Rong H Pernow Y et al. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia. Cancer Res 1998 58 4113 4116.
12. Bouizar Z Spyratos F Deytieux S de Vernejoul MC Jullienne A. Polimerase chain reaction analysis of parathyroid hormone-related protein expression in breast cancer patients and occurrence of bone metastasis. Cancer Res 1993 53 5076 5078.
13. Iwamura M Weicheng W Muramoto M et al. Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma. Cancer 1999 86 1028 1034.
14. Pardo FS Lien WW Fox HS et al. Parathyroid hormone-related protein expression is correlated with clinical course in patients with glial tumors. Cancer 2004 101 2622 2628.
15. Rizzoli R Thiebaud D Bundred N et al. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab 1999 84 3545 3550.
16. Truong NUB deB Edwardes MD Papavasiliou V Goltzman D Kremer R. Parathyroid hormone-related peptide and survival of patients with cancer and hypercalcemia. Am J Med 2003 115 115 121.
17. Aklilu F Park M Goltzman D Rabbani SA. Increased PTHRP production by a tyrosine kinase oncogene, Tpr-Met: Role of the Ras signaling pathway. Am J Physiol 1996 271 E277 E283.
18. Aklilu F Park M Goltzman D Rabbani SA. Induction of parathyroid hormone-related peptide by the Ras oncogene: Role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy. Cancer Res 1997 57 4517 4522.
19. Aklilu F Park M Goltzman D Rabbani SA. Role of mitogen-activated protein kinase in the induction of parathyroid hormone-related peptide. Cancer Res 2000 60 1753 1760.
20. Hoey RP Sanderson C Iddon J Brady G Bundred NJ Anderson NG. The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastasis and promotes autocrine proliferation in breast carcinoma cells. Br J Cancer 2003 88 567 573.
21. Esbrit P Alvarez-Arroyo MV De Miguel F Martin O Martinez ME Caramelo C. C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells. J Am Soc Nephrol 2000 11 1085 1092.
22. Akino K Ohtsuru A Kanda K et al. Parathyroid hormone-related peptide is a potent tumor angiogenic factor. Endocrinology 2000 141 4313 4316.